ReviewChinese medicine2021
Towards a better understanding of Fagopyrum dibotrys: a systematic review.
Review in Chinese medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 41 citations in OpenAlex.
- Epicatechin suppresses cancer stem-like cell phenotype and radioresistance in non-small cell lung cancer via targeting CXCL8.Biology direct · 2026Article
- Article
- Article
- DietaryAnimals : an open access journal from MDPI · 2025Article
- Phylogenomics provides comprehensive insights into the evolutionary relationships among cultivated buckwheat species.Genome biology · 2025Article
- Complete mitochondrial genome assembly and comparative analysis of Fagopyrum dibotrys (Golden Buckwheat).BMC plant biology · 2025Article
- Quality Evaluation of Decoction Pieces ofJournal of analytical methods in chemistry · 2025Article
- Effects ofFrontiers in veterinary science · 2025Article
- IL-33/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential.Frontiers in immunology · 2025Review
- Systematic analysis of the ARF gene family in Fagopyrum dibotrys and its potential roles in stress tolerance.Genetica · 2024Article
- Selenium Nanoparticles Regulate Antioxidant Enzymes and Flavonoid Compounds inPlants (Basel, Switzerland) · 2024Article
- Fagopyrum dibotrys extract improves nonalcoholic fatty liver disease via inhibition of lipogenesis and endoplasmic reticulum stress in high-fat diet-fed mice.BMC research notes · 2024Article
- Exploring the anti-inflammatory ingredients and potential of golden buckwheat (Food science & nutrition · 2024Article
- Genomics and resequencing ofFrontiers in plant science · 2024Article
- Article
- Identification of phytochemical compounds ofHeliyon · 2023Article
- Principal Components and Cluster Analysis of Trace Elements in Buckwheat Flour.Foods (Basel, Switzerland) · 2023Article
- Succession of endophytic fungi and rhizosphere soil fungi and their correlation with secondary metabolites inFrontiers in microbiology · 2023Article
- Dual Inhibition of HIV-1 and Cathepsin L Proteases byMolecules (Basel, Switzerland) · 2022Article
- Identification of Medicinal Compounds of Fagopyri Dibotryis Rhizome from Different Origins and Its Varieties Using UPLC-MS/MS-Based Metabolomics.Metabolites · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
Abstract
Fagopyrum dibotrys (F. dibotrys) (D.Don) H.Hara is a well-known edible herbal medicine in Asian countries. It has been widely used for the treatment of lung diseases, swelling, etc., and is also an important part of many Chinese medicine prescriptions. At present, more than 100 compounds have been isolated and identified from F. dibotrys, and these compounds can be primarily divided into flavonoids, phenols, terpenes, steroids, and fatty acids. Flavonoids and phenolic compounds are considered to be the main active ingredients of F. dibotrys. Previous pharmacological studies have shown that F. dibotrys possesses anti-inflammatory, anti-cancer, anti-oxidant, anti-bacterial, and anti-diabetic activities. Additional studies on functional genes have led to a better understanding of the metabolic pathways and regulatory factors related with the flavonoid active ingredients in F. dibotrys. In this paper, we systemically reviewed the research advances on the phytochemistry and pharmacology of F. dibotrys, as well as the functional genes related to the synthesis of active ingredients, aiming to promote the development and utilization of F. dibotrys.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.